TY - JOUR
T1 - Meeting the challenges of acne treatment in Asian Patients
T2 - A review of the role of dermocosmetics as adjunctive therapy
AU - Goh, Chee Leok
AU - Noppakun, Nopadon
AU - Micali, Giuseppe
AU - Azizan, Noor
AU - Boonchai, Waranya
AU - Chan, Yung
AU - Cheong, Wai
AU - Chiu, Pin
AU - Etnawati, Kristiana
AU - Gulmatico-Flores, Zharlah
AU - Foong, Henry
AU - Kubba, Raj
AU - Paz-Lao, Purita
AU - Lee, Yin
AU - Loo, Steven
AU - Modi, Farida
AU - Nguyen, Trong
AU - Pham, Thi
AU - Shih, Yi
AU - Sitohang, Irma Bernadette
AU - Wong, Su Ni
PY - 2016/4/1
Y1 - 2016/4/1
N2 -
Conventional acne treatment presents several challenges such as intolerable side effects and antibiotic resistance. Dermocosmetic products may be used to reduce these unwanted effects. Dermocosmetics include skin cleansers, topical sebum-controllers, skin antimicrobial/anti-inflammatory agents, moisturizers, sunscreens, and camouflage products. Appropriate use of these products may help augment the benefit of acne treatment, minimize side effects, and reduce the need for topical antibiotics. In Asia, there is currently limited scientific data on the application and recommendations for dermocosmetic use in acne vulgaris (AV). This article reviews the evidence on dermocosmetics for AV and provides practice recommendations as discussed during the 4
th
Asia-Pacific Acne Leaders' Summit held in Bangkok, Thailand, on 7 and 8 February 2015. Through a premeeting survey, a series of plenary lectures, a stepwise program of discussion sessions, and Medline article review, the Expert Panel set forth relevant recommendations on the role of dermocosmetics as adjunct for treating AV in Asian patients.
AB -
Conventional acne treatment presents several challenges such as intolerable side effects and antibiotic resistance. Dermocosmetic products may be used to reduce these unwanted effects. Dermocosmetics include skin cleansers, topical sebum-controllers, skin antimicrobial/anti-inflammatory agents, moisturizers, sunscreens, and camouflage products. Appropriate use of these products may help augment the benefit of acne treatment, minimize side effects, and reduce the need for topical antibiotics. In Asia, there is currently limited scientific data on the application and recommendations for dermocosmetic use in acne vulgaris (AV). This article reviews the evidence on dermocosmetics for AV and provides practice recommendations as discussed during the 4
th
Asia-Pacific Acne Leaders' Summit held in Bangkok, Thailand, on 7 and 8 February 2015. Through a premeeting survey, a series of plenary lectures, a stepwise program of discussion sessions, and Medline article review, the Expert Panel set forth relevant recommendations on the role of dermocosmetics as adjunct for treating AV in Asian patients.
KW - Acne
KW - adjuvant
KW - Asian
KW - cosmeceuticals
KW - dermocosmetics
UR - http://www.scopus.com/inward/record.url?scp=84977109355&partnerID=8YFLogxK
U2 - 10.4103/0974-2077.184043
DO - 10.4103/0974-2077.184043
M3 - Review article
AN - SCOPUS:84977109355
SN - 0974-2077
VL - 9
SP - 85
EP - 92
JO - Journal of Cutaneous and Aesthetic Surgery
JF - Journal of Cutaneous and Aesthetic Surgery
IS - 2
ER -